Resigned: Makary, Four FDA Leaders Out in a Week
Makary's exit triggered a cascade: four more FDA leaders gone in a week, and biotech wants Richard Pazdur next. The White House hasn't said yes.
Makary's exit triggered a cascade: four more FDA leaders gone in a week, and biotech wants Richard Pazdur next. The White House hasn't said yes.
TeamPCP breached GitHub via a poisoned VS Code extension, pulling approximately 3,800 internal repos now listed on criminal forums.
OCC's May 15 final rules preempt interest-on-escrow laws across 14 jurisdictions, but circuit splits with the First and Ninth keep the fight open.
Acceleron veterans bet Westlake BioPartners' $30M on ORJ-001, a first-in-class IPF peptide with Phase 1 data in hand and Phase 2 next.
Commure raised $70M at a $7B valuation, with General Catalyst doubling down on AI that automates 85% of hospital billing without human hands.
Wells Fargo agreed to a $110M discrimination settlement. The $100M goes to a new mortgage fund, not to the Black homeowners turned away in 2020.
A $1.4B Kelun bet pays off: Merck's sac-TMT is first in a global Phase 3 to beat chemo on OS and PFS in post-platinum endometrial cancer.
The SEC's 'innovation exemption' would let platforms tokenize Apple shares without issuer consent, and there's no limit on duplicate wrappers.
Colorado's AI Act just shed its discrimination controls; startups dodge impact assessments, but the safe harbor that protected them is gone.
Chairman Atkins just gave every company fighting an SEC enforcement action a new weapon: the right to publicly deny while still settling.
UK Treasury plans to ease ringfencing rules, freeing £80 billion in lending capacity for banks that argued the post-2008 rules cost too much.
A CISA contractor disabled GitHub's secret scanning before publishing AWS GovCloud admin keys and plaintext passwords to a public repository.
NYC's largest public health system had fingerprints and palm prints stolen, covering 1.8M people, with no explanation for why it stored biometrics.
Federal judge fines Cliq $6.5M for violating its 2015 FTC consent order, far below the $52.9M sought, but no receiver and no industry ban.
Anthropic will brief the G20's FSB on Mythos, which found thousands of high-severity vulnerabilities leaving many regulators on the outside.